First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)
====================================================================================================================================================

* Sophie Postel-Vinay
* Vincent K Lam
* Willeke Ros
* Todd M Bauer
* Aaron R Hansen
* Daniel C Cho
* F Stephen Hodi
* Jan H M Schellens
* Jennifer K Litton
* Sandrine Aspeslagh
* Karen A Autio
* Frans L Opdam
* Meredith McKean
* Neeta Somaiah
* Stephane Champiat
* Mehmet Altan
* Anna Spreafico
* Osama Rahma
* Elaine M Paul
* Christoph M Ahlers
* Helen Zhou
* Herbert Struemper
* Shelby A Gorman
* Maura Watmuff
* Kaitlin M Yablonski
* Niranjan Yanamandra
* Michael J Chisamore
* Emmett V Schmidt
* Axel Hoos
* Aurelien Marabelle
* Jeffrey S Weber
* John V Heymach